4//SEC Filing
Seehra Jasbir 4
Accession 0001209191-22-004771
CIK 0001664710other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 4:17 PM ET
Size
5.6 KB
Accession
0001209191-22-004771
Insider Transaction Report
Form 4
Seehra Jasbir
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2022-01-21+165,000→ 165,000 totalExercise: $46.30Exp: 2032-01-20→ Common Stock (165,000 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the shares subject to the option shall vest on January 19, 2023, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001732369
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 4:17 PM ET
- Size
- 5.6 KB